262 related articles for article (PubMed ID: 20338557)
1. Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes.
Wiltgen D; Spritzer PM
Fertil Steril; 2010 Nov; 94(6):2493-6. PubMed ID: 20338557
[TBL] [Abstract][Full Text] [Related]
2. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
[TBL] [Abstract][Full Text] [Related]
3. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Genazzani AR
Fertil Steril; 2009 Aug; 92(2):626-34. PubMed ID: 18706545
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.
Pehlivanov B; Orbetzova M
Gynecol Endocrinol; 2007 Oct; 23(10):604-9. PubMed ID: 17852429
[TBL] [Abstract][Full Text] [Related]
5. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
6. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
[TBL] [Abstract][Full Text] [Related]
7. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome.
Singh KB; Mahajan DK; Wortsman J
J Reprod Med; 1994 Oct; 39(10):805-8. PubMed ID: 7837128
[TBL] [Abstract][Full Text] [Related]
8. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
9. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome in polycystic ovary syndrome.
Carmina E
Minerva Ginecol; 2006 Apr; 58(2):109-14. PubMed ID: 16582867
[TBL] [Abstract][Full Text] [Related]
11. Not all women diagnosed with PCOS share the same cardiovascular risk profiles.
Jovanovic VP; Carmina E; Lobo RA
Fertil Steril; 2010 Aug; 94(3):826-32. PubMed ID: 19501355
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity.
Nácul AP; Andrade CD; Schwarz P; de Bittencourt PI; Spritzer PM
Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):191-6. PubMed ID: 17049715
[TBL] [Abstract][Full Text] [Related]
13. Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.
Spritzer PM; Comim FV; Capp E; D'Avila A
Horm Metab Res; 2005 Feb; 37(2):94-8. PubMed ID: 15778926
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS).
Macut D; Micić D; Cvijović G; Sumarac M; Kendereski A; Zorić S; Pejković D
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1353-59; discussion 1365. PubMed ID: 11964034
[TBL] [Abstract][Full Text] [Related]
17. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?
Abdel Fattah NS; Darwish YW
Br J Dermatol; 2009 May; 160(5):1011-5. PubMed ID: 19298279
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
